Research Associate at Center for Genetic Engineering and Biotechnology, Cuba
๐งช Dr. Fidel Ernesto Morales Vicente is an Auxiliary Researcher at the Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba. He holds a Ph.D. in Chemistry from the Federal University of Sรฃo Carlos, Brazil, specializing in covalent modifications of antimicrobial and anticancer peptides. With expertise in peptide synthesis, bioorganic chemistry, and biomedical research, he has led multiple research projects and industry collaborations. Dr. Morales has also served as a Teaching Assistant Professor at the University of Havana. His contributions advance therapeutic peptide development and organic synthesis.
Publication Profile
Google Scholar
๐ Education & Qualifications
Dr. Fidel Ernesto Morales Vicente is a distinguished chemist with a strong academic background. He earned his Ph.D. in Chemistry from the Federal University of Sรฃo Carlos, Brazil, focusing on covalent modifications of antimicrobial and anticancer peptides ๐งช. His Ph.D. was later homologated at the University of Havana, Cuba. He holds a Masterโs in Chemistry (2014) and a Bachelorโs in Chemistry (2012) from the University of Havana, graduating with a Gold Diploma ๐
. Dr. Morales has also been part of Cubaโs national preselection team for International Chemistry Olympiads ๐, demonstrating excellence in organic synthesis and peptide chemistry.
๐จโ๐ฌ Professional Experience
Dr. Fidel Ernesto Morales Vicente is an Auxiliary Researcher at the Peptide Synthetic Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana ๐งช. Previously, he served as a Research & Development Specialist at CIGB and led the Biomedical Research Group at the University of Havana ๐ฅ. He played a key role in a Company-University Agreement on therapeutic peptide modifications. Dr. Morales has extensive teaching experience as a Teaching Assistant Professor at the University of Havana ๐. His expertise spans organic synthesis, peptide chemistry, and biomedical research, contributing significantly to scientific advancements in Cuba and Brazil.
๐ Awards and Honors
Dr. Fidel Ernesto Morales Vicente has received multiple prestigious awards for his contributions to chemistry and biomedical research ๐๏ธ. In 2024, he won the Havana University Prize for his work on antifungal peptides ๐ฆ . He was honored with the CITMA Young Researcher Award in 2023 and the Special CITMA Award (2022) for his role in developing the Abdala COVID-19 vaccine ๐. His earlier accolades include the Cuban Academy of Science Prize (2016) and multiple Havana University Research Prizes. As a student, he earned Olympiad medals ๐
, including a Bronze Medal at the Iberoamerican Olympiad (2006).
๐ Teaching Experience
Dr. Fidel Ernesto Morales Vicente has extensive teaching experience in chemistry and peptide synthesis ๐งช. In 2023, he delivered a postgraduate course on Solid Phase Peptide Synthesis for the Masterโs in Biotechnology at the Center for Genetic Engineering and Biotechnology, Havana ๐ซ. He previously supervised teaching internships at the Federal University of Sรฃo Carlos, Brazil (2018) and taught the Chemical Reaction postgraduate course (2017). From 2012 to 2020, he lectured and assisted in General Chemistry courses at the University of Havana, guiding students in biochemistry, microbiology, and physical engineering ๐.
๐ฌ Research Focus
Dr. Fidel Ernesto Morales Vicente specializes in peptide chemistry, antimicrobial peptides, and bioorganic synthesis ๐งช. His research explores macrocyclization, multicomponent reactions, and peptide modifications for drug discovery ๐. He has contributed significantly to antifungal and antibacterial peptides, particularly Cm-p5 derivatives, targeting Candida auris and biofilm-related infections ๐ฆ . His expertise extends to peptide organocatalysis, peptide-steroid conjugation, and solid-phase peptide synthesis ๐ฌ. He also investigates peptide-lipid interactions, antifungal mechanisms, and peptide-based drug delivery. His work bridges synthetic chemistry, biotechnology, and pharmacology, making key advancements in therapeutic peptide development โ๏ธ.
Publication Top Notes
1๏ธโฃ Macrocyclization of Peptide Side Chains by the Ugi Reaction | J. Org. Chem. | ๐ 65 citations | ๐
2015
2๏ธโฃ A Multiple Multicomponent Approach to Chimeric PeptideโPeptoid Podands | Chem.โEur. J. | ๐ 63 citations | ๐
2013
3๏ธโฃ Aminocatalysis-Mediated on-Resin Ugi Reactions | Org. Lett. | ๐ 47 citations | ๐
2015
4๏ธโฃ Bidirectional Macrocyclization of Peptides | Org. Biomol. Chem. | ๐ 40 citations | ๐
2015
5๏ธโฃ Helical-Stabilized, Cyclic Peptide Cm-p5 with Antifungal Activity | ACS Omega | ๐ 36 citations | ๐
2019
6๏ธโฃ Cm-p5 Peptide Derivatives Inhibit Candida auris Biofilms | Antibiotics | ๐ 33 citations | ๐
2020
7๏ธโฃ CuI-Catalyzed AlkyneโAzide Cycloaddition in Peptide Conjugation | Tetrahedron | ๐ 27 citations | ๐
2014
8๏ธโฃ New Antibacterial Peptides from Freshwater Mollusk Pomacea poeyana | Biomolecules | ๐ 26 citations | ๐
2020
9๏ธโฃ Antimicrobial Peptides: Therapeutic Potential | Rev. Cubana Med. Trop. | ๐ 17 citations | ๐
2017
๐ Pom-1 and Pom-2 Peptides Active Against Candida Biofilms | Pathogens | ๐ 16 citations | ๐
2021